Literature DB >> 9916748

IFN-gamma induces endothelial cells to proliferate and to invade the extracellular matrix in response to the HIV-1 Tat protein: implications for AIDS-Kaposi's sarcoma pathogenesis.

V Fiorelli1, G Barillari, E Toschi, C Sgadari, P Monini, M Stürzl, B Ensoli.   

Abstract

Previous studies indicated that the Tat protein of HIV functions as a progression factor in Kaposi's sarcoma (KS), an angioproliferative disease common and aggressive in HIV-1-infected individuals (AIDS-KS). In particular, Tat that is released by infected cells stimulates the growth and invasion of spindle cells of endothelial origin derived from KS lesions (KS cells). Other work suggested that inflammatory cytokines may act as initiating factors in KS since they induce normal endothelial cells to acquire the same phenotype and functional features of KS cells, including the responsiveness to Tat. In this study, we show that among the inflammatory cytokines increased in AIDS-KS lesions, IFN-gamma alone is sufficient to induce endothelial cells to proliferate and to invade the extracellular matrix in response to Tat. This is because IFN-gamma up-regulates the expression and activity of the receptors for Tat identified as the integrins alpha5beta1 and alpha(v)beta3. These results suggest that, by triggering Tat effects, IFN-gamma plays a major role in AIDS-KS pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9916748

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathway.

Authors:  Elena Toschi; Ilaria Bacigalupo; Raffaele Strippoli; Chiara Chiozzini; Anna Cereseto; Mario Falchi; Filomena Nappi; Cecilia Sgadari; Giovanni Barillari; Fabrizio Mainiero; Barbara Ensoli
Journal:  Mol Biol Cell       Date:  2006-01-25       Impact factor: 4.138

Review 2.  Breaking down the barrier: the effects of HIV-1 on the blood-brain barrier.

Authors:  Marianne Strazza; Vanessa Pirrone; Brian Wigdahl; Michael R Nonnemacher
Journal:  Brain Res       Date:  2011-05-14       Impact factor: 3.252

3.  Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor.

Authors:  E Toschi; G Barillari; C Sgadari; I Bacigalupo; A Cereseto; D Carlei; C Palladino; C Zietz; P Leone; M Stürzl; S Buttò; A Cafaro; P Monini; B Ensoli
Journal:  Mol Biol Cell       Date:  2001-10       Impact factor: 4.138

Review 4.  Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma.

Authors:  Giovanni Barillari; Barbara Ensoli
Journal:  Clin Microbiol Rev       Date:  2002-04       Impact factor: 26.132

5.  tat Exon 1 exhibits functional diversity during HIV-1 subtype C primary infection.

Authors:  Raabya Rossenkhan; Iain J MacLeod; Theresa K Sebunya; Eduardo Castro-Nallar; Mary Fran McLane; Rosemary Musonda; Berhanu A Gashe; Vlad Novitsky; M Essex
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

Review 6.  The roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunction.

Authors:  Erik R Kline; Roy L Sutliff
Journal:  J Investig Med       Date:  2008-06       Impact factor: 2.895

7.  Angiogenesis, Kaposi's Sarcoma and Kaposi's Sarcoma-Associated Herpesvirus.

Authors:  Tao Kang; Feng-Chun Ye; Shou-Jiang Gao; Lin-Ding Wang
Journal:  Virol Sin       Date:  2008-12-01       Impact factor: 4.327

8.  Human immunodeficiency virus type 1 tat-mediated cytotoxicity of human brain microvascular endothelial cells.

Authors:  Naveed Ahmed Khan; Francescopaolo Di Cello; Avi Nath; Kwang Sik Kim
Journal:  J Neurovirol       Date:  2003-12       Impact factor: 2.643

9.  Inflammatory cytokines inhibit Kaposi's sarcoma-associated herpesvirus lytic gene transcription in in vitro-infected endothelial cells.

Authors:  Steven Milligan; Mairi Robinson; Elizabeth O'Donnell; David J Blackbourn
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

10.  Impact of Tat Genetic Variation on HIV-1 Disease.

Authors:  Luna Li; Satinder Dahiya; Sandhya Kortagere; Benjamas Aiamkitsumrit; David Cunningham; Vanessa Pirrone; Michael R Nonnemacher; Brian Wigdahl
Journal:  Adv Virol       Date:  2012-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.